Julian Levell

1.0k total citations
23 papers, 471 citations indexed

About

Julian Levell is a scholar working on Organic Chemistry, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Julian Levell has authored 23 papers receiving a total of 471 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Molecular Biology and 4 papers in Materials Chemistry. Recurrent topics in Julian Levell's work include Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Julian Levell is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Protein Degradation and Inhibitors (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Julian Levell collaborates with scholars based in United States, Germany and Switzerland. Julian Levell's co-authors include Alan R. Katritzky, Peter Czerney, Weihong Du, Richard Cummings, Matthew Segall, G. J. Conduit, Thomas M. Whitehead, Benedict Irwin, Nico Cantone and Robert J. Sims and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Julian Levell

22 papers receiving 458 citations

Peers

Countries citing papers authored by Julian Levell

Since Specialization

Citations

This map shows the geographic impact of Julian Levell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julian Levell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julian Levell more than expected).

Fields of papers citing papers by Julian Levell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julian Levell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julian Levell. The network helps show where Julian Levell may publish in the future.

Co-authorship network of co-authors of Julian Levell

This figure shows the co-authorship network connecting the top 25 collaborators of Julian Levell. A scholar is included among the top collaborators of Julian Levell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julian Levell. Julian Levell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification and characterization of second-generation EZH2 inhibitors with extended residence times and improved biological activity 2021 ·Journal of Biological Chemistry ·Jacob I. Stuckey, Nico Cantone, Alexandre Côté, Shilpi Arora, Valérie Vivat, Ashwin Ramakrishnan, Jennifer A. Mertz, (unknown), Jehrod Brenneman, Victor Gehling, Ludivine Moine, Robert J. Sims, James E. Audia, Patrick Trojer, Julian Levell, Richard Cummings	9
2	765 The first-in-class small molecule TREX1 inhibitor CPI-381 demonstrates type I IFN induction and sensitization of tumors to immune checkpoint blockade 2021 ·SHILAP Revista de lepidopterología ·(unknown), A.S. Gardberg, Valérie Vivat, Lei Cui, (unknown), Nico Cantone, Jacob I. Stuckey, Florence Poy, (unknown), Richard Cummings, Jonathan E. Wilson, Julian Levell, Jennifer L. Rocnik, Patrick Trojer	3
3	Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors 2020 ·ACS Medicinal Chemistry Letters ·Victor Gehling, John P. McGrath, Martin Duplessis, (unknown), (unknown), Rishi G. Vaswani, Alexandre Côté, Jacob I. Stuckey, (unknown), Richard Cummings, Srividya Balasubramanian, Priyadarshini Iyer, (unknown), Andrew C. Good, Brian K. Albrecht, Jean-Christophe Harmange, James E. Audia, Steven F. Bellon, Patrick Trojer, Julian Levell	18
4	Practical Applications of Deep Learning To Impute Heterogeneous Drug Discovery Data 2020 ·Journal of Chemical Information and Modeling ·Benedict Irwin, Julian Levell, Thomas M. Whitehead, Matthew Segall, G. J. Conduit	39
5	Early Drug‐Discovery Efforts towards the Identification of EP300/CBP Histone Acetyltransferase (HAT) Inhibitors 2020 ·ChemMedChem ·(unknown), A.S. Gardberg, Florence Poy, (unknown), Valérie Vivat, Nico Cantone, (unknown), Chirag Patel, Richard Cummings, Robert J. Sims, Julian Levell, James E. Audia, Archana Bommi‐Reddy, Jonathan E. Wilson	14
6	Discovery of CPI-1612: A Potent, Selective, and Orally Bioavailable EP300/CBP Histone Acetyltransferase Inhibitor 2020 ·ACS Medicinal Chemistry Letters ·Jonathan E. Wilson, (unknown), Chirag Patel, (unknown), (unknown), A.S. Gardberg, Florence Poy, Nico Cantone, Archana Bommi‐Reddy, Robert J. Sims, Richard Cummings, Julian Levell	43
7	Design, Synthesis, and Pharmacological Evaluation of Second Generation EZH2 Inhibitors with Long Residence Time 2020 ·ACS Medicinal Chemistry Letters ·(unknown), Alexandre Côté, Shilpi Arora, Ludivine Moine, Victor Gehling, Jehrod Brenneman, Nico Cantone, Jacob I. Stuckey, (unknown), Ashwin Ramakrishnan, (unknown), William D. Bradley, James E. Audia, Richard Cummings, Robert J. Sims, Patrick Trojer, Julian Levell	27
8	Abstract 4722: Efficacy of a novel EP300/CBP histone acetyltransferase inhibitor in hormone responsive breast cancer 2019 ·Archana Bommi‐Reddy, (unknown), (unknown), Esteban Terzo, Florence Poy, Sungmi Park, Michael J. Steinbaugh, Barbara M. Bryant, Andrew R. Conery, Richard D. Cummings, Julian Levell, Robert J. Sims	1
9	Isocitrate Dehydrogenase (IDH) Mutations Promote a Reversible ZEB1/MicroRNA (miR)-200-dependent Epithelial-Mesenchymal Transition (EMT) 2012 ·Journal of Biological Chemistry ·Alexandra Grassian, Fallon Lin, Rosemary Barrett, Yue Liu, Wei Jiang, Manav Korpal, Holly Astley, Daniel P. Gitterman, (unknown), Rob Howes, Julian Levell, Joshua M. Korn, Raymond Pagliarini	83
10	Structure-based library design and the discovery of a potent and selective mast cell β-tryptase inhibitor as an oral therapeutic agent 2011 ·Bioorganic & Medicinal Chemistry Letters ·Guyan Liang, Suzanne C. Aldous, (unknown), Julian Levell, (unknown), Jennifer Cairns, Xin Chen, S. Maignan, Magali Mathieu, (unknown), (unknown), Sam Rebello, (unknown), Isabelle Morize, Henry W. Pauls	16
11	New hypotheses about the structure–function of proprotein convertase subtilisin/kexin type 9: Analysis of the epidermal growth factor‐like repeat A docking site using WaterMap 2010 ·Proteins Structure Function and Bioinformatics ·Robert A. Pearlstein, Qiying Hu, Jing Zhou, David Yowe, Julian Levell, (unknown), Virendar K. Kaushik, Douglas S. Daniels, (unknown), Woody Sherman, Robert Abel	58
12	Design, synthesis, and biological activity of potent and selective inhibitors of mast cell tryptase 2005 ·Bioorganic & Medicinal Chemistry Letters ·Corey R. Hopkins, (unknown), Steven S. Kaye, (unknown), (unknown), Henry W. Pauls, Guyan Liang, (unknown), (unknown), Jennifer Cairns, (unknown), (unknown), (unknown), Sam Rebello, (unknown), A. Dupuy, Magali Mathieu, Julian Levell	29
13	間接的な求電子的置換反応によるベンゾ[b]ピリリウム塩の分子エンジニアリング 1998 ·European Journal of Organic Chemistry ·A.R. Katritzky, Peter Czerney, Julian Levell, (unknown)	1
14	Molecular Engineering of Benzo[b]pyrylium Salts by Indirect Electrophilic Substitution 1998 ·European Journal of Organic Chemistry ·Alan R. Katritzky, Peter Czerney, Julian Levell, Weihong Du	39
15	Cyclopropylidene Derivatives via Low-Valent Titanium-Induced Dehydroxylative Debenzotriazolylation of 1- and 2-(Cyclopropylbenzotriazolyl)carbinols 1998 ·The Journal of Organic Chemistry ·Alan R. Katritzky, Weihong Du, Julian Levell, Jianqing Li	0
16	Benzotriazole-Mediated Conversions of para-H-Substituted Pyrylium, Benzo[b]pyrylium, and Xanthylium Salts into para-Position Functionalized Derivatives (An Indirect Electrophilic Substitution of Electron-Deficient Heteroaromatics) 1997 ·The Journal of Organic Chemistry ·Alan R. Katritzky, Peter Czerney, Julian Levell	37
17	Regioselectivity of Deprotonation of Indoline and Tetrahydroquinoline Dithiocarbamic and Carbamic Compounds: A Correction 1997 ·Synthesis ·H. AHLBRECHT, (unknown), (unknown), Alan R. Katritzky, Ion Ghiviriga, Julian Levell	3
18	Novel Photochromic Naphthopyran DerivativesV/ANew General Synthetic Methodology 1997 ·Molecular crystals and liquid crystals science technology. Section A, Molecular crystals and liquid crystals ·H.G. Heller, Julian Levell, David E. Hibbs, David S. Hughes, Michael B. Hursthouse	4
19	A new indole synthesis via [3+3] annulation of 2-(benzotriazol-1-ylmethyl)-pyrroles with α,β-unsaturated aldehydes and ketones 1996 ·Tetrahedron Letters ·Alan R. Katritzky, Julian Levell, Jianqing Li	18
20	The intramolecular [2 + 4] cycloaddition reaction of E,E-9-anthrylmethylene-[1-(2,5-dimethyl-3-furylethylidene)]succinic anhydride 1995 ·Journal of the Chemical Society Chemical Communications ·H.G. Heller, David S. Hughes, Michael B. Hursthouse, Julian Levell, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact